Quarter Period Statement Of Income

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7316362

Concept 2024-03-01 to
2024-05-31
2023-03-01 to
2023-05-31
Quarter period statement of income
Statement of income
Net sales
35,810,000,000 JPY
32,096,000,000 JPY
Cost of sales
15,005,000,000 JPY
13,378,000,000 JPY
Gross profit (loss)
20,804,000,000 JPY
18,718,000,000 JPY
Selling, general and administrative expenses
16,655,000,000 JPY
14,356,000,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
4,149,000,000 JPY
4,361,000,000 JPY
Non-operating income
Interest income
728,000,000 JPY
470,000,000 JPY
Dividend income
119,000,000 JPY
90,000,000 JPY
Non-operating income
1,562,000,000 JPY
1,413,000,000 JPY
Non-operating expenses
Interest expenses
4,000,000 JPY
0 JPY
Non-operating expenses
149,000,000 JPY
61,000,000 JPY
Ordinary profit (loss)
5,562,000,000 JPY
5,713,000,000 JPY
Extraordinary income
Extraordinary income
1,354,000,000 JPY
JPY
Extraordinary losses
Extraordinary losses
0 JPY
0 JPY
Profit (loss) before income taxes
6,915,000,000 JPY
5,712,000,000 JPY
Income taxes
1,944,000,000 JPY
1,533,000,000 JPY
Profit (loss)
4,971,000,000 JPY
4,179,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.